Objective To understand the different types of chronic hepatitis group in shenzhen area E viral hepatitis (hepatitis E infection status and provide scientific basis for the prevention and treatment of hepatitis E.Methods Randomly collected from July 2013 to June 2015 in shenahen Longhua New District People’s Hospital without hepatitis normal physical exami-nation and treatment group 1746 cases as control group,chronic hepatitis B viral hepatitis (hepatitis B)the crowd of 1 320 cases of hepatitis B,chronic viral hepatitis C (HCV)population group,615 cases of hepatitis C,respectively,the application method of enzyme-linked immunosorbent assay (ELISA)to detect serum hepatitis E antibody (anti HEV IgG)-IgG,ana-lyzed of different types of hepatitis a crowd hepatitise infection status,and compared the hepatitise infection rate if there was a difference between the different groups.Results 1 746 cases of control group in serum anti HEV-IgG positive rate was 3.49% (61/1 746),4.22% of men and women in 2.68%.1 320 cases of hepatitis B group was 10.9%,12.29% of men and women in 8.23%.615 cases of C group was 10.2%,12.35% of men and women in 7.64%.Hepatitis B and C group of HEV-IgG positive rate compared with control group difference was statistically significant (χ2 =9.163~9.405,P <0.05), and hepatitis B and hepatitis C group there was no statistically significant difference between positive HEV-resistant IgG (χ2=0.614,P >0.614),and hepatitis E infection rate than women,men was statistically significant difference (χ2 =2.873~4.025,P <0.05).Conclusion Chronic hepatitis B and C viral hepatitis crowd anti HEV-IgG positive rate was higher than normal people,no hepatitis hepatitis E infection rate among men than women.Therefore,strengthens to the chronic hepatitis B and C viral hepatitis a crowd of early discovery,early diagnosis and early treatment,to reduce hepatitis E infection rate has an important significance.

Objective To evaluate the value of carcino embryonic antigen(CEA),carbohydrate antigen 19,cytokeratin(CYFRA21-1),squamous cell cancer antigen(SCC) and neuron specific enolase(NSE) for the evaluation of chemotherapy response in the patients with advanced lung cancer.Methods One hundred and thirty-six patients with advanced lung cancer(lung cancer group) and 40 patients with lung benign disease(control group) were collected.The lung cancer group was treated with at least two courses of chemotherapy.The CYFRA21-1,SCC,CEA and NSE levels before chemotherapy were compared among the lung cancer group,control group and the patients with different pathological types.The above mentioned tumor markers levels before and after chemotherapy were compared among the patients with different curative effects in the lung cancer group.Results The levels of serum NSE,CYFRA21-1,CEA and SCC before treatment in the lung cancer group were higher than those in the control group(P<0.01);the serum CEA level of the squamous carcinoma group was higher than that of the adenocarcinoma group and the small cell carcinoma group(P<0.01),and the serum NSE level of the small cell carcinoma group was higher than that of the adenocarcinoma and squamous cell carcinoma group(P<0.01),and the levels of CYFRA21-1 and SCC of the squamouscarcinoma group were higher than those of the adenocarcinoma and small cell groups(P<0.01).The serum CEA level of patial remission(PR) patients in adenocarcinoma group was significantly decreased(P<0.01),the serum SCC level of PR patients in the squamous cell carcinoma group was significantly decreased(P<0.05),and the serum NSE level of PR patients in small cell carcinoma group was significantly decreased after chemotherapy(P<0.01).The difference of serum NSE,CYFRA21-1 and SCC after chemotherapy in stnble and prosgoressive patients of various groups were not statistically significant(P>0.05).Conclusion CEA,CYFRA21-1,SCC and NSE can be used as the effective evaluation indexes of chemotherapy in lung adenocarcinoma,lung squamous cell carcinoma and small cell carcinoma,but which has little significance in the patients without effect of chemotherapy.

OBJECTIVE: To evaluate the therapeutic efficacy and pharmacoeconomic results of 3 varieties antihistamines in the treatment of chronic idiopathic urticaria. METHODS: 96 patients with idiopathic urticaria were randomly divided into Group A, B and C, treated with mizolastine ,cetirizine and loratatine for 28 days, respectively. The therapeutic effects and recurrence within 7 days after drug withdrawl were observed, and the results were analyzed using cost-minimization analysis. RESULTS: The effective rates in Group A, B, and C were 96.7%, 94.1% and 93.8%, respectively. The recurrent rates within 7 days after discontinuation of the treatment were 40.0%, 35.3% and28.1%, respectively . The cost of drugs were 116.76 yuan, 45.64 yuan and 128.8 yuan, respectively. CONCLUSION: Cetirizine is the preferable treatment prescription for idiopathic urticaria